Tableau de bordPortefeuillesListe de surveillanceCommunautéDécouvrirFiltre
NOT FOR DISTRIBUTION

H.B. Fuller Company

NYSE:FUL Rapport sur les actions

Capitalisation boursière : US$2.8b

  • Présentation de l'entreprise
  • Évaluation
  • Croissance future
  • Performances passées
  • Santé financière
  • Dividende
  • Gestion
  • Propriété
  • Autres informations
  • Communauté boursière

H.B. Fuller Croissance future

Future contrôle des critères 1/6

H.B. Fuller devrait augmenter ses bénéfices et son chiffre d'affaires de 9.3% et de 7% par an respectivement. Le BPA devrait croître de de 9.1% par an. Le rendement des capitaux propres devrait être 13.3% dans 3 ans.

Informations clés

9.3%

Taux de croissance des bénéfices

9.11%

Taux de croissance du BPA

Chemicals croissance des bénéfices21.7%
Taux de croissance des recettes7.0%
Rendement futur des capitaux propres13.26%
Couverture par les analystes

Good

Dernière mise à jour20 Aug 2026

Mises à jour récentes de la croissance future

Article d’analyse • Sep 30

H.B. Fuller Company Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year

Shareholders might have noticed that H.B. Fuller Company ( NYSE:FUL ) filed its quarterly result this time last week...

Recent updates

Seeking Alpha • Aug 13

H.B. Fuller Company's Complexity Offers Potential

Summary H.B. Fuller Company remains a Buy candidate, with recent improvements in revenue and profitability despite prior underperformance and share price decline. FUL’s acquisition of Advanced Medical Solutions Group expands its total addressable market by $15 billion, but increases leverage and hinges on realizing $55 million in synergies. The company is evaluating an unsolicited $1.1–$1.2 billion cash offer for its Building Adhesives Solutions segment, which could reduce debt but permanently lower profitability. Current valuation is attractive, but investors must be comfortable with heightened uncertainty from M&A activity and restructuring efforts. Read the full article on Seeking Alpha
User avatar
Mise à jour du récit • Jun 30

FUL: Medical Deal And Earnings Execution Will Drive Future Upside Potential

H.B. Fuller’s analyst price target has shifted from $70.43 to $73.29. Analysts point to updated assumptions around revenue growth, profit margins, valuation multiples and recent research moves that include several price target increases and an upgraded rating.
Article d’analyse • Jun 18

H.B. Fuller (FUL) Stock Could Be 8% Undervalued After Its 2025 Sustainability Report

H.B. Fuller (FUL) is in focus after publishing its 2025 Sustainability Report, which sets out 2030 goals on greenhouse gas emissions, water use, and waste intensity, and links these efforts to operations and customer demand. See our latest analysis for H.B. Fuller. Recent trading suggests momentum in H.B. Fuller stock has been picking up, with a 30 day share price return of 11.27% and a 90 day share price return of 28.74%. The 1 year total shareholder return of 21.62% gives investors context...
User avatar
Mise à jour du récit • Jun 16

FUL: Medical Deal Uncertainty And Activist Pressure Will Shape Future Outlook

Analysts have made a small, valuation-driven adjustment to their view on H.B. Fuller, with the blended price target holding close to prior levels as updated models reflect a slightly lower discount rate, largely stable fair value at about $70, and balanced input from recent upgrades and price target revisions across the Street. Analyst Commentary Recent commentary on H.B. Fuller centers on how potential corporate actions and updated models could influence the stock’s risk and reward profile, with JPMorgan’s upgrade and various price target changes framing a mixed but valuation conscious view.
User avatar
Mise à jour du récit • Jun 02

FUL: Proposed Medical Solutions Deal Will Shape Long Term Outlook

Analysts kept their fair value estimate for H.B. Fuller steady at $70.43 while adjusting assumptions such as the discount rate and long-term growth. This reflected mixed recent price target moves as firms reassessed the stock around potential corporate actions and valuation.
User avatar
Mise à jour du récit • Apr 26

FUL: Raised Guidance And P/E Assumptions Will Support Stronger Long Term Outlook

Analysts have adjusted their outlook on H.B. Fuller, with offsetting moves such as a $3 increase in the price target at Citi and a $3 reduction at UBS. These changes are framed around updated views on valuation inputs such as the discount rate and the assumed future P/E multiple.
User avatar
Mise à jour du récit • Apr 12

FUL: Long Term Assumptions Will Support Balanced Outlook Despite Mixed Guidance

The analyst price target for H.B. Fuller edges slightly lower to about $70.43 from roughly $70.71, as analysts balance recent target increases from several firms with more cautious revisions tied to adjusted growth, margin, and P/E assumptions. Analyst Commentary Recent Street research on H.B. Fuller presents a mixed picture, with several firms adjusting price targets both higher and lower over the past few months.
User avatar
Mise à jour du récit • Mar 29

FUL: Higher Long Term Assumptions Will Support Upside Despite Mixed Guidance

Analysts trimmed the average H.B. Fuller price target by about $1 to $70.71, reflecting a mix of recent upward and downward revisions as they reassessed assumptions on growth, profitability, and valuation multiples. Analyst Commentary Recent research on H.B. Fuller features a mix of higher and lower price targets.
User avatar
Mise à jour du récit • Mar 14

FUL: Higher P/E Assumptions Will Support Upside Despite Muted Revenue Outlook

Analysts have lifted their consolidated price target on H.B. Fuller by several dollars, with recent $2 to $6 upward revisions tied to their updated views on the company’s earnings power and P/E assumptions. Analyst Commentary Bullish analysts raising their targets by $2 to $6 are largely reacting to updated assumptions on H.B. Fuller’s earnings power and the P/E they are willing to apply to those earnings.
User avatar
Mise à jour du récit • Feb 28

FUL: Free Cash Flow Support Will Offset Modest Outlook And Future P/E Assumptions

H.B. Fuller’s analyst price target has been lifted by several firms, with recent increases of $2 to $6 reflecting analysts’ updated views on its earnings profile and modest adjustments to assumptions such as discount rate, long-term revenue growth, profit margin, and future P/E. Analyst Commentary Recent Street research points to a cluster of higher price targets for H.B. Fuller, with adjustments in the range of $2 to $6.
User avatar
Mise à jour du récit • Feb 14

FUL: Free Cash Flow Support Will Balance Organic Headwinds And Future P/E Expectations

The Street has nudged its view on H.B. Fuller higher, with analysts lifting price targets by $2 to $6 as they point to a mix of free cash flow support and valuation considerations, even as they flag near term organic growth headwinds. Analyst Commentary Recent Street research clusters around a common theme for H.B. Fuller, with price target increases framed against ongoing pressure on near term organic growth.
User avatar
Mise à jour du récit • Jan 31

FUL: Free Cash Flow Support Will Underpin Higher Future P/E Expectations

Analysts have lifted their price targets on H.B. Fuller by between $2 and $6, citing updated views on valuation, free cash flow support, and a slightly higher assumed future P/E multiple in their models. Analyst Commentary Recent research updates show a cluster of higher price targets for H.B. Fuller, with several firms revisiting their models to reflect revised valuation assumptions, free cash flow support, and modestly higher assumed future P/E multiples.
User avatar
Mise à jour du récit • Jan 17

FUL: Higher P/E Expectations Will Shape Medium Term Earnings Power

Analysts have raised their price targets for H.B. Fuller, reflected in the fair value estimate increasing from $68.83 to $71.71. This change is based on a higher assumed future P/E multiple, along with slightly revised assumptions for the discount rate, revenue growth, and profit margins.
Article d’analyse • Jan 08

Investors Will Want H.B. Fuller's (NYSE:FUL) Growth In ROCE To Persist

What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Article d’analyse • Nov 14

We Think H.B. Fuller (NYSE:FUL) Is Taking Some Risk With Its Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Article d’analyse • Oct 03

There May Be Reason For Hope In H.B. Fuller's (NYSE:FUL) Disappointing Earnings

Soft earnings didn't appear to concern H.B. Fuller Company's ( NYSE:FUL ) shareholders over the last week. Our analysis...
Article d’analyse • Sep 30

H.B. Fuller Company Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year

Shareholders might have noticed that H.B. Fuller Company ( NYSE:FUL ) filed its quarterly result this time last week...
User avatar
Mise à jour du récit • Sep 28

ND Industries Integration And HHC Pricing Will Secure Stability

Analysts have raised H.B. Fuller's price target to $68.83, citing confidence in continued EBITDA growth, margin expansion, and operational execution despite a weak growth environment. Analyst Commentary Bullish analysts highlight solid year-over-year EBITDA growth expected in fiscal 2025, despite a sluggish growth environment.
Article d’analyse • Aug 30

Estimating The Intrinsic Value Of H.B. Fuller Company (NYSE:FUL)

Key Insights Using the 2 Stage Free Cash Flow to Equity, H.B. Fuller fair value estimate is US$53.78 With US$61.05...
Article d’analyse • Aug 14

H.B. Fuller Company's (NYSE:FUL) P/E Is On The Mark

H.B. Fuller Company's ( NYSE:FUL ) price-to-earnings (or "P/E") ratio of 31.7x might make it look like a strong sell...
Article d’analyse • Jul 30

Is Now The Time To Look At Buying H.B. Fuller Company (NYSE:FUL)?

While H.B. Fuller Company ( NYSE:FUL ) might not have the largest market cap around , it saw a double-digit share price...
Article d’analyse • Jul 15

There's Been No Shortage Of Growth Recently For H.B. Fuller's (NYSE:FUL) Returns On Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...
Article d’analyse • May 22

Is H.B. Fuller Company (NYSE:FUL) Worth US$54.7 Based On Its Intrinsic Value?

Key Insights Using the 2 Stage Free Cash Flow to Equity, H.B. Fuller fair value estimate is US$41.64 H.B. Fuller is...
Article d’analyse • May 07

H.B. Fuller (NYSE:FUL) Takes On Some Risk With Its Use Of Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Article d’analyse • Apr 19

H.B. Fuller (NYSE:FUL) Will Pay A Larger Dividend Than Last Year At $0.235

The board of H.B. Fuller Company ( NYSE:FUL ) has announced that it will be increasing its dividend by 5.6% on the 13th...
Article d’analyse • Apr 10

Here's What To Make Of H.B. Fuller's (NYSE:FUL) Decelerating Rates Of Return

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
Article d’analyse • Mar 13

Shareholders Should Be Pleased With H.B. Fuller Company's (NYSE:FUL) Price

With a price-to-earnings (or "P/E") ratio of 22.4x H.B. Fuller Company ( NYSE:FUL ) may be sending bearish signals at...
Article d’analyse • Feb 21

What Is H.B. Fuller Company's (NYSE:FUL) Share Price Doing?

H.B. Fuller Company ( NYSE:FUL ), is not the largest company out there, but it saw significant share price movement...
Article d’analyse • Jan 23

We Think You Can Look Beyond H.B. Fuller's (NYSE:FUL) Lackluster Earnings

Shareholders appeared unconcerned with H.B. Fuller Company's ( NYSE:FUL ) lackluster earnings report last week. We...
Seeking Alpha • Jan 17

Evaluation Of H.B. Fuller After A 30% Decline

Summary H.B. Fuller missed analysts' estimates for the second consecutive quarter, leading to a 3% stock decline and hitting a nearly 3-year low. Despite recent stagnation, H.B. Fuller expects to realize price hikes in 2025, with projected earnings per share growth of 5% and potential for significant future gains. The stock's sharp 30% decline is attributed to its initially high valuation; it now trades at a more reasonable 15.0x forward P/E ratio. Given its cyclical nature, H.B. Fuller offers substantial upside potential but is not a long-term hold; investors should reassess at $79 target. Read the full article on Seeking Alpha

Prévisions de croissance des bénéfices et des revenus

NYSE:FUL - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
11/30/20284,1702422233934
11/30/20273,9232121843067
11/30/20263,6372091513287
5/30/20263,508186141323N/A
2/28/20263,456160145312N/A
11/29/20253,474152121263N/A
8/30/20253,502115121242N/A
5/31/20253,528103118231N/A
3/1/20253,54711373202N/A
11/30/20243,569130163302N/A
8/31/20243,548183256378N/A
6/1/20243,531165272399N/A
3/2/20243,512154305420N/A
12/2/20233,511145259378N/A
9/2/20233,566148283425N/A
6/3/20233,607157231374N/A
3/4/20233,702164151280N/A
12/3/20223,749180127257N/A
8/27/20223,688183-16101N/A
5/28/20223,57416810124N/A
2/26/20223,40917050160N/A
11/27/20213,278161117213N/A
8/28/20213,158151207300N/A
5/29/20213,023161218303N/A
2/27/20212,870144241333N/A
11/28/20202,790124239332N/A
8/29/20202,752115209302N/A
5/30/20202,786123212300N/A
2/29/20202,871128N/A303N/A
11/30/20192,897131N/A269N/A
8/31/20192,926140N/A307N/A
6/1/20192,971128N/A308N/A
3/2/20193,001136N/A286N/A
12/1/20183,041171N/A253N/A
9/1/20182,951123N/A177N/A
6/2/20182,744111N/A130N/A
3/3/20182,51692N/A92N/A
12/2/20172,30659N/A166N/A
9/2/20172,203105N/A121N/A
6/3/20172,153113N/A146N/A
3/4/20172,124120N/A170N/A
12/3/20162,095122N/A196N/A
8/27/20162,068110N/A203N/A
5/28/20162,079104N/A172N/A
2/27/20162,08797N/A182N/A
11/28/20152,08488N/A205N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de FUL ( 9.3% par an) est supérieure au taux d'épargne ( 3.7% ).

Bénéfices vs marché: Les bénéfices de FUL ( 9.3% par an) devraient croître plus lentement que le marché US ( 17.3% par an).

Croissance élevée des bénéfices: Les bénéfices de FUL devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de FUL ( 7% par an) devrait croître plus lentement que le marché de US ( 13.5% par an).

Croissance élevée des revenus: Le chiffre d'affaires de FUL ( 7% par an) devrait croître plus lentement que 20% par an.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de FUL devrait être faible dans 3 ans ( 13.3 %).


Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/09/10 19:42
Cours de l'action en fin de journée2026/09/10 00:00
Les revenus2026/05/30
Revenus annuels2025/11/29

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
  • Formulaire 10-K de la SEC
  • Formulaire 10-Q de la SEC
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
  • Rapports de recherche des analystes
  • Blue Matrix
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
  • Données de marché ICE
  • Formulaire S-1 de la SEC
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
  • Formulaire 4 de la SEC
  • Formulaire 13D de la SEC
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
  • Formulaire 10-K de la SEC
  • Formulaire SEC DEF 14A
Principaux développements10 ans
  • Annonces de l'entreprise
  • Formulaire 8-K de la SEC

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.

Découvrez l' qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

H.B. Fuller Company est couverte par 12 analystes. 7 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Ghansham PanjabiBaird
Paretosh MisraBerenberg
Patrick CunninghamCitigroup Inc

Prenez de meilleures décisions d’investissement partout

Scannez pour télécharger
Ouvrir l’App StoreOuvrir Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Voir les sources de données
Marchés
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Idées d'investissement
  • Sociétés sous-évaluées
  • Les géants du dividende
  • Achats d'initiés
  • Énergie nucléaire
  • Véhicules autonomes
  • Intelligence artificielle
  • Cryptomonnaie et blockchain
  • cybersécurité
  • Plus d'idées
Communautés boursières
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Outils et fonctionnalités
  • Suivi de portefeuille
  • Filtre et alertes sur les actions
  • Narratives et valeurs équitables
  • Calculateur de dividendes
Actualités et découvertes
  • Dernières actualités de stock
  • Aperçus du marché mondial
  • Le Foxhole
  • Idées d'investissement
  • Narratives de la communauté
  • Quoi de neuf
Simply Wall St
  • Plans et tarifs
  • Publicité
  • À propos de nous
  • Nous contacter
  • Carrières
  • Centre d'aide
  • Apprendre à investir en bourse
  • Programme d'affiliation
  • Affaires et entreprises
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Conditions générales d'utilisation
  • Politique de confidentialité
  • Conditions relatives à l'IA
  • Guide des services financiers